Detailed Information on Publication Record
2019
Comparison of Active Substance Losses and Total Weight Losses of Tablets Administered Via Feeding Tube
PAPIEŽ, Adriána, Klara ODEHNALOVA, Vladimír ŠRÁMEK and Pavel SUKBasic information
Original name
Comparison of Active Substance Losses and Total Weight Losses of Tablets Administered Via Feeding Tube
Authors
PAPIEŽ, Adriána (703 Slovakia, belonging to the institution), Klara ODEHNALOVA (203 Czech Republic), Vladimír ŠRÁMEK (203 Czech Republic, belonging to the institution) and Pavel SUK (203 Czech Republic, guarantor, belonging to the institution)
Edition
PHARMACOLOGY, BASEL, KARGER, 2019, 0031-7012
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.625
RIV identification code
RIV/00216224:14110/19:00109118
Organization unit
Faculty of Medicine
UT WoS
000464384500004
Keywords in English
Dosage forms; Drug administration routes; Nasogastric tube; Intensive care; High-pressure liquid chromatography
Tags
International impact, Reviewed
Změněno: 18/12/2019 14:26, Mgr. Tereza Miškechová
Abstract
V originále
Background/Aims: Administration of tablets via feeding tube (FT) is often associated with significant drug losses, as was confirmed by weighing. The aim of this study was to measure the proportion of active substance losses (ASLs) in an in vitro model. Methods: A film-coated tablet (FilmCT) containing clopidogrel (Trombex (R)) and a tablet with enteric coating (EntericCT) containing pantoprazole (Controloc (R)) were crushed in a mortar and transferred by method A (tablet powder was transferred into the beaker, poured into the syringe and water added) and method B (water was added into the mortar, suspension drawn into the syringe) and administered via FT in an in vitro model. Total losses were measured with analytical balance and, simultaneously, ASL were analyzed with high-performance liquid chromatography UV-detection (HPLC-UV). Results: ASL was different to weighing only in the case of EntericCT prepared by method B (2.0 +/- 4.2 and 10.7 +/- 0.8% for HPLC-UV and weighing, respectively; p = 0.004). HPLC-UV confirmed significantly lower ASL when method B was used for either EntericCT (34.3 +/- 7.2 vs. 2.0 +/- 4.2%; p < 0.001) or FilmCT (14.1 +/- 2.2 vs. 7.7 +/- 4.1%; p < 0.01). Conclusion: Drug loss analysis with analytical balance may overestimate ASL, as was proved for EntericCT in this study. ASL were significantly lower when method B was used.